https://www.ibtimes.com.au/aim-immunotech-stock-today-aim-surges-44-massive-volume-after-patent-approval-cancer-trial-1863809
AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial...
Mar 19, 2026 - OCALA, Fla. — Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy...
https://aimimmuno.com/
AIM Immunotech | Immunology for a Better Future
for a better futureaimimmunotechimmunology